292 related articles for article (PubMed ID: 22610518)
1. Cucurbit[7]uril encapsulated cisplatin overcomes cisplatin resistance via a pharmacokinetic effect.
Plumb JA; Venugopal B; Oun R; Gomez-Roman N; Kawazoe Y; Venkataramanan NS; Wheate NJ
Metallomics; 2012 Jun; 4(6):561-7. PubMed ID: 22610518
[TBL] [Abstract][Full Text] [Related]
2. A cisplatin slow-release hydrogel drug delivery system based on a formulation of the macrocycle cucurbit[7]uril, gelatin and polyvinyl alcohol.
Oun R; Plumb JA; Wheate NJ
J Inorg Biochem; 2014 May; 134():100-5. PubMed ID: 24595010
[TBL] [Abstract][Full Text] [Related]
3. A chemical preformulation study of a host-guest complex of cucurbit[7]uril and a multinuclear platinum agent for enhanced anticancer drug delivery.
Kennedy AR; Florence AJ; McInnes FJ; Wheate NJ
Dalton Trans; 2009 Oct; (37):7695-700. PubMed ID: 19759943
[TBL] [Abstract][Full Text] [Related]
4. Cucurbit [7] uril encapsulated cisplatin overcomes resistance to cisplatin induced by Rab25 overexpression in an intraperitoneal ovarian cancer model.
Gomez-Roman N; McGregor F; Wheate NJ; Plumb JA
J Ovarian Res; 2015 Sep; 8():62. PubMed ID: 26384969
[TBL] [Abstract][Full Text] [Related]
5. Cucurbit[n]uril binding of platinum anticancer complexes.
Wheate NJ; Buck DP; Day AI; Collins JG
Dalton Trans; 2006 Jan; (3):451-8. PubMed ID: 16395444
[TBL] [Abstract][Full Text] [Related]
6. The Effect of Cucurbit[7]uril on the Antitumor and Immunomodulating Properties of Oxaliplatin and Carboplatin.
Pashkina E; Aktanova A; Mirzaeva I; Kovalenko E; Andrienko I; Knauer N; Pronkina N; Kozlov V
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298956
[TBL] [Abstract][Full Text] [Related]
7. Host-Guest Interactions between Oxaliplatin and Cucurbit[7]uril/Cucurbit[7]uril Derivatives under Pseudo-Physiological Conditions.
Wu H; Chen H; Tang B; Kang Y; Xu JF; Zhang X
Langmuir; 2020 Feb; 36(5):1235-1240. PubMed ID: 31941282
[TBL] [Abstract][Full Text] [Related]
8. Orthogonal self-assembly of an organoplatinum(II) metallacycle and cucurbit[8]uril that delivers curcumin to cancer cells.
Datta S; Misra SK; Saha ML; Lahiri N; Louie J; Pan D; Stang PJ
Proc Natl Acad Sci U S A; 2018 Aug; 115(32):8087-8092. PubMed ID: 30038010
[TBL] [Abstract][Full Text] [Related]
9. Toxicity of cucurbit[7]uril and cucurbit[8]uril: an exploratory in vitro and in vivo study.
Uzunova VD; Cullinane C; Brix K; Nau WM; Day AI
Org Biomol Chem; 2010 May; 8(9):2037-42. PubMed ID: 20401379
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of anionic half generation 3.5-6.5 poly(amidoamine) dendrimers as delivery vehicles for the active component of the anticancer drug cisplatin.
Kirkpatrick GJ; Plumb JA; Sutcliffe OB; Flint DJ; Wheate NJ
J Inorg Biochem; 2011 Sep; 105(9):1115-22. PubMed ID: 21704583
[TBL] [Abstract][Full Text] [Related]
11. pH-sensitive polymeric cisplatin-ion complex with styrene-maleic acid copolymer exhibits tumor-selective drug delivery and antitumor activity as a result of the enhanced permeability and retention effect.
Saisyo A; Nakamura H; Fang J; Tsukigawa K; Greish K; Furukawa H; Maeda H
Colloids Surf B Biointerfaces; 2016 Feb; 138():128-37. PubMed ID: 26674841
[TBL] [Abstract][Full Text] [Related]
12. Cucurbit[7]uril: an emerging candidate for pharmaceutical excipients.
Kuok KI; Li S; Wyman IW; Wang R
Ann N Y Acad Sci; 2017 Jun; 1398(1):108-119. PubMed ID: 28692768
[TBL] [Abstract][Full Text] [Related]
13. Interference with the expression of β-catenin reverses cisplatin resistance in A2780/DDP cells and inhibits the progression of ovarian cancer in mouse model.
Zhao H; Wei W; Sun Y; Gao J; Wang Q; Zheng J
DNA Cell Biol; 2015 Jan; 34(1):55-62. PubMed ID: 25211326
[TBL] [Abstract][Full Text] [Related]
14. Targeted Polypeptide-Microtubule Aggregation with Cucurbit[8]uril for Enhanced Cell Apoptosis.
Zhang YM; Liu JH; Yu Q; Wen X; Liu Y
Angew Chem Int Ed Engl; 2019 Jul; 58(31):10553-10557. PubMed ID: 31165539
[TBL] [Abstract][Full Text] [Related]
15. Overcoming cisplatin resistance of ovarian cancer cells by targeted liposomes in vitro.
Krieger ML; Eckstein N; Schneider V; Koch M; Royer HD; Jaehde U; Bendas G
Int J Pharm; 2010 Apr; 389(1-2):10-7. PubMed ID: 20060458
[TBL] [Abstract][Full Text] [Related]
16. Encapsulation of platinum(II)-based DNA intercalators within cucurbit[6,7,8]urils.
Kemp S; Wheate NJ; Wang S; Collins JG; Ralph SF; Day AI; Higgins VJ; Aldrich-Wright JR
J Biol Inorg Chem; 2007 Sep; 12(7):969-79. PubMed ID: 17653578
[TBL] [Abstract][Full Text] [Related]
17. Supramolecular co-encapsulation of a photosensitizer and chemotherapeutic drug in cucurbit[8]uril for potential chemophototherapy.
Solis-Egaña F; Lavín-Urqueta N; Guerra Díaz D; Mariño-Ocampo N; Faúndez MA; Fuentealba D
Photochem Photobiol Sci; 2022 Mar; 21(3):349-359. PubMed ID: 35088367
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the stability of cucurbit[8]uril-based ternary host-guest complexation in physiological environment and the fabrication of a supramolecular theranostic nanomedicine.
Wu H; Chen Z; Qi S; Bai B; Ye J; Wu D; Shen J; Kang F; Yu G
J Nanobiotechnology; 2021 Oct; 19(1):330. PubMed ID: 34670552
[TBL] [Abstract][Full Text] [Related]
19. XIAP gene downregulation by small interfering RNA inhibits proliferation, induces apoptosis, and reverses the cisplatin resistance of ovarian carcinoma.
Ma JJ; Chen BL; Xin XY
Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):222-6. PubMed ID: 19758744
[TBL] [Abstract][Full Text] [Related]
20. Acyclic Cucurbit[n]uril-Type Molecular Container Enables Systemic Delivery of Effective Doses of Albendazole for Treatment of SK-OV-3 Xenograft Tumors.
Hettiarachchi G; Samanta SK; Falcinelli S; Zhang B; Moncelet D; Isaacs L; Briken V
Mol Pharm; 2016 Mar; 13(3):809-18. PubMed ID: 26756920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
